Human colon cancer-specific antigen-3,CCSA-3 ELISA Kit

Contact us for 48 wells and bulk quote

Introducing the Human Colon Cancer-Specific Antigen-3, CCSA-3 ELISA Kit, a cutting-edge solution designed to facilitate accurate detection and quantification of CCSA-3 in human colon cancer samples. This advanced kit is meticulously crafted to meet the stringent requirements of researchers and clinicians in the field of oncology.

The Human Colon Cancer-Specific Antigen-3, CCSA-3 ELISA Kit employs a highly sensitive enzyme-linked immunosorbent assay (ELISA) technique, enabling the precise measurement of CCSA-3 levels in a variety of biological specimens. With its exceptional specificity and sensitivity, this kit empowers users to unravel the intricate dynamics of CCSA-3 expression, thereby contributing to a deeper understanding of colon cancer pathogenesis.

Crafted with utmost precision, the Human Colon Cancer-Specific Antigen-3, CCSA-3 ELISA Kit guarantees reliable and reproducible results, ensuring the utmost confidence in experimental outcomes. Its user-friendly design and comprehensive instructions enable seamless integration into laboratory workflows, facilitating efficient and streamlined experimentation.

This state-of-the-art kit is meticulously validated and optimized to deliver exceptional performance across a wide range of sample types, including serum, plasma, and tissue extracts. Its broad dynamic range and low detection limit enable the accurate quantification of CCSA-3, even in samples with low concentrations, thereby enhancing the diagnostic potential of this kit.

The Human Colon Cancer-Specific Antigen-3, CCSA-3 ELISA Kit is an indispensable tool for researchers and clinicians seeking to unravel the intricate mechanisms underlying colon cancer progression. With its unparalleled accuracy, sensitivity, and ease of use, this kit represents a significant advancement in the field of oncology research, paving the way for enhanced diagnostic and therapeutic strategies in the fight against colon cancer.